A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo ...

New research presented at the European Congress on Obesity (ECO2025) in Malaga, Spain (11–14 May) reveals that adverse ...

A Cornell University project to save babies born with serious heart defects has lost key funding just days after it was ...

Individuals who lived with obesity as children are less likely to be in work or studying in their mid-20s than their peers, ...

President Donald Trump has long been preoccupied by the trade deficit—the gap between what the U.S. sells to the rest of the ...

Smartwatches and other wearable devices can feel almost magical. Strap on a Fitbit, Apple Watch or Samsung Gear and you're ...

Knowing the calorie content of foods does not help people understand which foods are healthier, according to a study I ...

Many patients suffer not only from respiratory symptoms due to their COVID-19 disease, but also from significantly reduced ...

Biomedical engineers at Duke University have developed a novel imaging system that harnesses the power of artificial ...

For neurodegenerative diseases such as Alzheimer's and Parkinson's, treatment options are scant. New research by Stanford ...

Personalized feedback interventions (PFIs), a common strategy for helping college students moderate their alcohol use, can ...

Researchers at Novartis BioMedical Research in the US and Switzerland have identified a molecular target that may provide a ...